A la une
UK – NICE recommends olaparib for BRCA-mutated breast cancer treatment
The National Institute for Health and Care Excellence (NICE) has given a positive recommendation for Lynparza (olaparib) for NHS use in England and Wales.
This...
Europe – MDCG 2024-7 Rev. 1 Preliminary assessment review template...
This document has been endorsed by the Medical Device Coordination Group (MDCG) established by Article 103 of Regulation (EU) 2017/745. The MDCG is composed...
Europe – MDCG 2022-3 rev.1 – Verification of manufactured class D...
Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) establishes
the requirements for notified bodies involved in the conformity assessment of applicable classes of...
France – « Cash Investigation ». Pénuries de médicaments : les labos font-ils...
Pour le troisième hiver consécutif, la France fait face à un phénomène inquiétant : les pénuries de médicaments. En 2023, près de 5 000 références de médicaments...
